|
Almus Pharmaceuticals has added eight lines to its generics range as part of an expansion designed to "better meet the needs of customers and patients". The new lines include: 30-tablet... |
|
Allergan has launched ‘triple-action' eye drops to treat moderate to severe dry eye symptoms. Optive Plus features new "lipid-enhancing technology" designed to prevent moisture in the eye... |
|
Natural healthcare company Nelsons has boosted its website with the addition of interactive tools designed to make consumers more aware of their health needs. NelsonsNaturalWorld.com now... |
|
Carnation Footcare has launched a summer-themed counter display unit for pharmacies to encourage sales of its footcare products. The stands will be available for pharmacies to display in May... |
|
Mentholatum is supporting its Deep Relief and Deep Heat products with a TV and press advertising campaign that forms part of a £2 million spend across the Deep portfolio this year. The... |
|
Internis Pharmaceuticals has launched a licensed vitamin D3 capsule in the UK, Fultium-D3 800IU. The prescription-only capsules contain the equivalent of 20mcg of vitamin D3, and a pack of... |
|
Members of the public have been urged to consult their pharmacist about sun protection after a survey revealed 92 per cent of visitors to a skin cancer roadshow had been sunburnt. ... |
|
Acne treatment OXY10 is now back in stock following production issues, manufacturer Mentholatum has confirmed. The product, which contains 10 per cent benzoyl peroxide, can be ordered through... |
|
Teva has launched generic galantamine hydrobromide capsules, indicated for mild to moderately severe dementia of the Alzheimer's type. The Zeebral XL Prolonged Release Capsules come in 8mg, 16mg... |
|
Internis Pharmaceuticals has launched swallowable calcium/ vitamin D3 tablet Accrete-D3. The manufacturer will be promoting the pharmacy-only tablets, which each contain a twice-daily dose of... |
Sign up for...
Keep up to date with all the latest news in pharmacy, the NHS, training and CPD. Sign up below or find out more.
